000131242 001__ 131242 000131242 005__ 20241125101201.0 000131242 0247_ $$2doi$$a10.1111/jdv.19427 000131242 0248_ $$2sideral$$a136792 000131242 037__ $$aART-2023-136792 000131242 041__ $$aeng 000131242 100__ $$aMisery, Laurent 000131242 245__ $$aWhite paper on psychodermatology in Europe: A position paper from the EADV Psychodermatology Task Force and the European Society for Dermatology and Psychiatry (ESDaP) 000131242 260__ $$c2023 000131242 5060_ $$aAccess copy available to the general public$$fUnrestricted 000131242 5203_ $$aPsychodermatology is a subspecialty of dermatology that is of increasing interest to dermatologists and patients. The case for the provision of at least regional psychodermatology services across Europe is robust. Psychodermatology services have been shown to have better, quicker and more cost‐efficient clinical outcomes for patients with psychodermatological conditions. Despite this, psychodermatology services are not uniformly available across Europe. In fact many countries have yet to establish dedicated psychodermatology services. In other countries psychodermatology services are in development. Even in countries where psychodermatolgy units have been established, the services are not available across the whole country. This is especially true for the provision of paediatric psychodermatology services. Also whilst most states across Europe are keen to develop psychodermatology services, the rate at which this development is being implemented is very slow. Our paper maps the current provision of psychodermatology services across Europe and indicates that there is still very much more work to be done in order to develop the comprehensive psychodermatology services across Europe, which are so crucial for our patients. 000131242 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/ 000131242 590__ $$a8.5$$b2023 000131242 592__ $$a1.686$$b2023 000131242 591__ $$aDERMATOLOGY$$b5 / 94 = 0.053$$c2023$$dQ1$$eT1 000131242 593__ $$aInfectious Diseases$$c2023$$dQ1 000131242 593__ $$aDermatology$$c2023$$dQ1 000131242 594__ $$a10.7$$b2023 000131242 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000131242 700__ $$aSchut, Christina 000131242 700__ $$aBalieva, Flora 000131242 700__ $$aBobko, Svetlana 000131242 700__ $$aReich, Adam 000131242 700__ $$aSampogna, Francesca 000131242 700__ $$aAltunay, Ilknur 000131242 700__ $$aDalgard, Florence 000131242 700__ $$aGieler, Uwe 000131242 700__ $$aKupfer, Jörg 000131242 700__ $$aLvov, Andrey 000131242 700__ $$aPoot, Françoise 000131242 700__ $$aSzepietowski, Jacek C. 000131242 700__ $$0(orcid)0000-0003-1917-6906$$aTomás-Aragonés, Lucia 000131242 700__ $$aVulink, Nienke 000131242 700__ $$aZalewska-Janowska, Anna 000131242 700__ $$aBewley, Anthony 000131242 773__ $$g37, 12 (2023), 2419-2427$$pJEADV, J. Eur. Acad. Dermatol. Venereol.$$tJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY$$x0926-9959 000131242 8564_ $$s190953$$uhttps://zaguan.unizar.es/record/131242/files/texto_completo.pdf$$yVersión publicada 000131242 8564_ $$s2220025$$uhttps://zaguan.unizar.es/record/131242/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000131242 909CO $$ooai:zaguan.unizar.es:131242$$particulos$$pdriver 000131242 951__ $$a2024-11-22-12:11:43 000131242 980__ $$aARTICLE